CSI Market
Sign In | Register

Genedx Holdings (WGS) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access WGS quarterly Cash Flow →
Reviewing cash flow figures over time highlights how Genedx Holdings balances operational cash generation with investment and financing decisions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-21.02
Depreciation & amortization25.22
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-3.30
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total0.00
Share-based Compensation32.16
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction1.20
Noncash Lease Expense-
Increase Decrease In Due To From Related Parties-
Change In Third Party Payor Reserves2.45
Gain Loss On Debt Forgiveness-
Income taxes3.16
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-36.23
Increase (Decrease) in Accounts Payable and Accrued Liabilities12.10
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.00
Other Working Capital11.97
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities5.56
Discontinued operations0.00
Net Cash flow from Operating Activities33.28
Investing Activities
Capital Expenditures-19.02
Sale of Capital Items0.00
Short-term Investments Proceeds46.03
Payments to Acquire Marketable Securities-55.68
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired-32.86
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-61.52
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-1.21
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock51.69
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Deferred Offering Costs Included In Accrued Offering Costs-
Payment For Settlement Of Unvested Stock Appreciation Rights-
Finance Lease Principal Payments-2.45
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities48.03
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow14.26
Total Cash Flow19.79
4 historic quarters locked

Sign in to unlock the full Genedx Holdings cash flow history.

Sign In Create Free Account

About Genedx Holdings Corp Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 23, 2026
  • Source: wgs-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001818331-26-000015

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License